Call for Abstract
5th Global Pharmacists Annual Meeting, will be organized around the theme “Expanded Role of Pharmacist for Better Patient Care and to Increase Public Awareness”
Pharmacists 2016 is comprised of 14 tracks and 67 sessions designed to offer comprehensive sessions that address current issues in Pharmacists 2016.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Clinical pharmacy is the area of practice in which pharmacists provides patient care that optimises medication therapy and promotes health, wellness and disease prevention. Clinical pharmacists rely on their professional relationships with patients to tailor their advice to best meet individual patient needs and desires. BCC estimates the total market for the clinical healthcare IT technologies covered in this report at more than $6.3 billion in 2010. The market is projected to grow to approximately $7.4 billion in 2011 and nearly $17.5 billion in 2016, a compound annual growth rate (CAGR) of 18.7% over the next 5 years.
- Track 1-1Role of Clinical Pharmacists
- Track 1-2Drug Information
- Track 1-3Monitoring of Drug Utilization
- Track 1-4Drug Evaluation and Selection
- Track 1-5Medication Therapy Management
- Track 1-6Quality, Safety and Standards
- Track 1-7Hematology and Oncology Pharmacists
The missions of the hospital pharmacists is to be part of the medication management in hospitals, which encompasses the entire way in which medicines are selected, procured, delivered, prescribed, administered and reviewed to optimise the contribution that medicines make to producing informed and desired outcomes to enhance the safety and quality of all medicine related processes affecting patients of the hospital to ensure the 7 “rights” are respected: right patient, right dose, right route, right time, right drug with the right information and documentation. The global inpatient and outpatient pharmacy automation market was valued at $2.4 billion in 2011 and should reach $2.6 billion in 2012. Total market value is expected to reach nearly $3.9 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 8%.
- Track 2-1Role of Hospital Pharmacists
- Track 2-2Total Parental Nutrition
- Track 2-3Patient Compliance
- Track 2-4Pediatric Pharmacists
- Track 2-5Veterinary Pharmacists
- Track 2-6Drug Interactions
Pharmacists provide an invaluable interface in this process by liaising with scientists and clinicians across the development arena. Within clinical research, pharmacists can help assess the safety and efficacy of new medicines. Skills learnt during pharmacy training allow them to contribute to the entire clinical trial process from planning the trial, developing the prototype formulations for administration first in animals and later for trials in humans, the production, packaging, labelling and supply of the medicine to clinical researchers, through to the monitoring and reporting of complex studies. In 2000, expenditure on research and development in United States, Europe and Japan countries came to a total of some 45 billion U.S. dollars.
- Track 3-1New Drug Discovery
- Track 3-2 Manufacturing Technology
- Track 3-3 Formulation of Drug products
- Track 3-4Medicines Policy and Governance
- Track 3-5Quality Assuarance and Safety
- Track 3-6Medicine Access and Rational Use
Industrial pharmacy includes manufacturing, marketing and distribution of drug products including quality assurance of these activities. The statistic depicts the worldwide revenue of the pharmaceutical market from 2001 to 2014. In 2001, worldwide revenue was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars.
- Track 4-1Industrial Pharmaceutics
- Track 4-2Drug Design and Development
- Track 4-3Drug Evaluation
- Track 4-4Production Hurdles
- Track 4-5Analytical Pharmacists
- Track 4-6Regulatory Pharmacists
Academic pharmacists engage in education, pharmaceutical practice, and research in schools of pharmacy. These three aspects of academic activity are interrelated, and at the same time connected with manpower planning and management. As of March 31, 2014 there were 48,815 pharmacists in Great Britain which is an increase of 2.96 percent on 2013.
- Track 5-1Clinician Educator
- Track 5-2Academic Research Pharmacists
- Track 5-3 International Health-related Organisations
- Track 5-4 Public service and Patient Care
- Track 5-5Consultancy work
- Track 5-6Technicians
Based on International Pharmaceutical Federation (FIP) the guidelines for Good Pharmaceutical Practice were first laid in 1993. And further used as reference by national pharmaceutical organisations, governments, and international pharmaceutical organizations to set up nationally accepted standards. The aim is to "contribute to health improvement and to help patients with health problems to make the best use of their medicines. This statistic shows total medicines expenditure worldwide in 2010 and 2015, and provides a forecast for 2020. In 2010, total spending on medicine was 887 billion U.S. dollars. It is estimated that until 2020 the pharmaceutical market will increase to around 1.4 trillion U.S. dollars.
- Track 6-1Good Pharmaceutical Practice (GPP)
- Track 6-2Patient Safety
- Track 6-3Professional Practice Standards
- Track 6-4Pharmacists Practice Guidelines
- Track 6-5Improvement in Pharmacy Practice
Community pharmacists are the health professionals most accessible to the public and other health professionals in primary health care. They supply medicines in accordance with a prescription or, when legally permitted, sell them without a prescription. In addition to ensuring an accurate supply of appropriate products, their professional activities also cover counselling of patients at the time of dispensing of prescription and non-prescription drugs, drug information to health professionals, patients and the general public, and participation in health-promotion programmes. In England in 2014/15 978.3 million items were dispensed by community pharmacies (92.1 per cent of all items dispensed in the community). This is an increase of 30.1 million (3.2 per cent) from 2013/14 when the figure was 948.2 million. This compares with 85.0 million items dispensed by dispensing practices and 7.8 million by appliance contractors in 2014/15. 14.7 per cent of items dispensed by community pharmacies and appliance contractors were via the Electronic Prescription Service.
- Track 7-1Role of Community Pharmacists
- Track 7-2Pharmaceutical Care
- Track 7-3Pharmacotherapy
- Track 7-4Health Promotion
- Track 7-5Compounding Pharmacists
- Track 7-6Dispensing Pharmacists
- Track 7-7Vaccination and Immunization
- Track 7-8Primary care Pharmacists
Nuclear Pharmacy is a specialty practice of pharmacy defined as a patient-oriented service embodying the scientific knowledge and professional judgment required to improve and promote health through the safe and efficacious use of radioactive drugs for diagnosis and therapy. By 2015, total revenues of pharmaceutical and medicine manufacture in Canada are projected to reach approximately 10.69 billion U.S. dollars.
- Track 8-1 Radiopharmaceutical Quality and Purity
- Track 8-2Clinical Applications
- Track 8-3Regulatory Aspects
- Track 8-4PET Radiopharmaceutical Update
Ambulatory care pharmacy is a fairly new focus for pharmacists and work in both an institutional and community-based clinic involved in direct care of a diverse patient population. This statistic shows the channels consumers use for health care, personal care and pharmacy services when shopping in the United Kingdom (UK), as a percentage of survey respondents. Of respondents, 36 percent said they shopped out of town for health, personal care and pharmacy services. This survey was conducted in October 2013.
- Track 9-1Pharmaco Therapy Services
- Track 9-2Collaborative Prescription
- Track 9-3Diagnostic authority
Home Care Pharmacy provides a large selection of healthcare and home medical equipment that helps public to be safe and independent in the home. This statistic shows the top therapy areas in developed pharmaceutical markets as projected in 2018, sorted by spending in billion US dollars. By 2018, expenditure on oncologists in these markets is projected to reach between 71 and 81 billion U.S. dollars.
- Track 10-1Scope of Home Health Care
- Track 10-2Medication Management
- Track 10-3 Reconciliation for Elderly
- Track 10-4Goals and objectives of HHC
- Track 10-5Home Infusion Pharmacy Services
A pharmacist working in a managed care environment is intimately involved in the care and course of pharmaceutical treatment and plays a vital role in contributing to positive patient outcomes. The areas of opportunities for pharmacists to coordinate patient care include but are not limited to data integration, communication management with physicians and patient outcomes research efforts, drug utilization review, disease management, academic detailing, cost analysis programs, and pharmacy benefit design. In addition, pharmacists are able to qualify and quantify the results of different therapies and programs, and therefore add value to the health care team. BCC estimates the total market for the clinical healthcare IT technologies covered in this report at more than $6.3 billion in 2010. The market is projected to grow to approximately $7.4 billion in 2011 and nearly $17.5 billion in 2016, a compound annual growth rate (CAGR) of 18.7% over the next 5 years.
- Track 11-1Drug Distribution and Dispensing
- Track 11-2Patient Safety
- Track 11-3Clinical Program Development
- Track 11-4Drug Benefit Design
- Track 11-5Business Management
To promote a mutual understanding of regional harmonisation initiatives in order to facilitate the harmonisation process related to ICH Guidelines regionally and globally, and to facilitate the capacity of drug regulatory authorities and industry to utilise them. The statistic depicts the worldwide revenue of the pharmaceutical market from 2001 to 2014. In 2001, worldwide revenue was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars.
- Track 12-1Pharmacists in Australia
- Track 12-2Pharmacists in Europe
- Track 12-3Pharmacists in Asia
- Track 12-4Pharmacists in Africa
- Track 12-5Pharmacists in north America
- Track 12-6Pharmacists in south america
Since about the year 2000, a growing number of Internet Pharmacies have been established worldwide. Many of these pharmacies are similar to community pharmacies, and in fact, many of them are actually operated by brick-and-mortar community pharmacies that serve consumers online and those that walk in their door. The primary difference is the method by which the medications are requested and received. Some customers consider this to be more convenient and private method rather than traveling to a community drugstore where another customer might overhear about the drugs that they take. Internet pharmacies are also recommended to some patients by their physicians if they are home bound. This statistic shows the channels consumers use for health care, personal care and pharmacy services when shopping in the United Kingdom (UK), as a percentage of survey respondents. Of respondents, 36 percent said they shopped out of town for health, personal care and pharmacy services. This survey was conducted in October 2013.
5th Global Pharmacists Annual meeting aims to highlight interesting facts from the CEOs & Directors of all promising new-age Pharmaceutical companies and how they managed to create global footprint so a speacial tract 'Enterpreneurs Investment Meet' is designed for the same. The statistic depicts the worldwide revenue of the pharmaceutical market from 2001 to 2014. In 2001, worldwide revenue was around 390.2 billion U.S. dollars. Ten years later, this figure stood at almost one trillion U.S. dollars.